N-甲基-N-((3R,4R)-4-甲基哌啶-3-基-7H-吡咯并[2,3-d]嘧啶-4-胺
英文名: N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine 别名:N-甲基-N-((3R,4R)-4-甲基-3-哌啶基)-7H-吡咯并[2,3-d]嘧啶-4-胺;N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺;N-甲基-N-[(3R,4R)-4-甲基-3-哌啶基]-7H-吡咯并[2,3-d]嘧啶-4-胺;托法替尼杂质M;托法替尼中间体;N-甲基-N-((3R,4R)-4-甲基哌啶-3-基-7H-吡咯并[2,3-d]嘧啶-4-胺
商品编号:R076835-100mg 规格:100mg 纯度:95%
CAS号: 477600-74-1 分子式:C13H19N5 分子量:245.32
价格
¥ 80.00
(请 登录 会员查看折扣价)
货期 5~7个工作日
数量
中文名称: N-甲基-N-((3R,4R)-4-甲基哌啶-3-基-7H-吡咯并[2,3-d]嘧啶-4-胺
中文别名: N-甲基-N-((3R,4R)-4-甲基-3-哌啶基)-7H-吡咯并[2,3-d]嘧啶-4-胺;N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺;N-甲基-N-[(3R,4R)-4-甲基-3-哌啶基]-7H-吡咯并[2,3-d]嘧啶-4-胺;托法替尼杂质M;托法替尼中间体;N-甲基-N-((3R,4R)-4-甲基哌啶-3-基-7H-吡咯并[2,3-d]嘧啶-4-胺
smiles: C[C@@H]1CCNC[C@@H]1N(C)C2=CN=C3C2=CN=CN3
英文名称: N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
英文别名: N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine;tofacitinib intermediate;7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-;N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine HCl;N-methyl-N-[(3R,4R)-4-methylpiperidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;N-methyl-N-[(3R,4R)-4-methyl-3-piperidyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;XRIARWQZLGCQDM-KOLCDFICSA-N;XRIARWQZLGCQDM-KOLCDFICSA-N;AC-24274;AC-24274;477600-74-1;477600-74-1;MFCD09878608;MFCD09878608;Tofacitinib Impurity M;Tofacitinib Impurity M;AMY40127;AMY40127;AKOS005258732;AKOS005258732;CS-B0706;CS-B0706;N-methyl-N-[(3R,4R)-4-methyl piperidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;TD92PJW2H4;N-methyl-N-[(3R,4R)-4-methyl piperidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;1H-Pyrrolo[2,3-d]pyrimidin-4-amine,N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-;TD92PJW2H4;methyl-[(3R,4R)-4-methyl-piperidin-3-yl]-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amine;1H-Pyrrolo[2,3-d]pyrimidin-4-amine,N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-;7H-Pyrrolo(2,3-d)pyrimidin-4-amine, N-methyl-N-((3R,4R)-4-methyl-3-piperidinyl)-;methyl-[(3R,4R)-4-methyl-piperidin-3-yl]-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amine;A26940;7H-Pyrrolo(2,3-d)pyrimidin-4-amine, N-methyl-N-((3R,4R)-4-methyl-3-piperidinyl)-;Methyl-((3R,4R)-4-methyl-piperidin-3-yl)-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amine;A26940;7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-, rel-;Methyl-((3R,4R)-4-methyl-piperidin-3-yl)-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amine;1206825-36-6;7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-, rel-;UNII-TD92PJW2H4;1206825-36-6;Methyl-((3R,4R)4-methyl-piperidin-3-yl)-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amine;UNII-TD92PJW2H4;N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine;CS-13040;Methyl-((3R,4R)4-methyl-piperidin-3-yl)-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amine;DTXSID70633602;N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine;Tofacitinib Impurity 11;CS-13040;SCHEMBL1120755;DTXSID70633602;J-523688;Tofacitinib Impurity 11;AU-004/43508412;SCHEMBL1120755;methyl-[(3R,4R)-4-methyl-piperidin-3-yl]-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amine;J-523688;A827336;AU-004/43508412;N-methyl-N-(4-methyl-3-piperidinyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine;methyl-[(3R,4R)-4-methyl-piperidin-3-yl]-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amine;AKOS015899957;A827336;N-methyl-N-(4-methyl-3-piperidinyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine;AKOS015899957
CAS号: 477600-74-1
分子式: C13H19N5
分子量: 245.32
密度:
熔点:
沸点:
闪点:
水溶性:
蒸气压:
搜索质检报告(COA)
搜索MSDS
相关产品